elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q27852097-D8EBF10E-266E-491D-888C-479D09699ECD
Q27852097-D8EBF10E-266E-491D-888C-479D09699ECD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27852097-D8EBF10E-266E-491D-888C-479D09699ECD
Multicenter phase I trial of the mitogen-activated protein kinase 1/2 inhibitor BAY 86-9766 in patients with advanced cancer.
P31
Q27852097-D8EBF10E-266E-491D-888C-479D09699ECD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27852097-D8EBF10E-266E-491D-888C-479D09699ECD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
81e544ac2f7729c0e8e75cbc0a1868ede7082972
P31
scholarly article